- Home
- AUTL vs ITRG Comparison
AUTL vs ITRG Comparison
Compare AUTL & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | ITRG |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 482.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUTL | ITRG |
|---|---|---|
| Price | $1.67 | $4.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $8.33 | $4.13 |
| AVG Volume (30 Days) | ★ 2.4M | 1.8M |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $51,128,000.00 | ★ $219,125,000.00 |
| Revenue This Year | $669.49 | $965.93 |
| Revenue Next Year | $91.53 | $9.39 |
| P/E Ratio | ★ N/A | $56.81 |
| Revenue Growth | ★ 406.67 | N/A |
| 52 Week Low | $1.11 | $0.79 |
| 52 Week High | $2.80 | $4.69 |
Technical Indicators
Market Signals| Indicator | AUTL | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 57.88 | 70.65 |
| Support Level | $1.63 | $4.24 |
| Resistance Level | $1.79 | $4.69 |
| Average True Range (ATR) | 0.09 | 0.25 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 59.09 | 78.37 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.